Comprehensive Insight Into Atopic Dermatitis: Understanding Disease Burden, Treatment Strategies and Emerging Therapies : Episode 7

Integrating New AD Therapies Into Clinical Practice

April 9, 2025

By Matthew Zirwas, M.D.

Opinion

Video

An expert discusses key considerations dermatologists should keep in mind when integrating newer therapies into their clinical practice, including implementing protocols for patient monitoring and promoting treatment adherence.

EP: 1.Clinical Presentations of Atopic Dermatitis Across Patient Populations

EP: 2.Hidden Burden of AD

EP: 3.Topical Treatments in AD

EP: 4.Shared Decision-Making in AD Management

EP: 5.Overcoming Barriers to Treatment in AD

EP: 6.Recent Advancements in AD Treatment

Now Viewing

EP: 7.Integrating New AD Therapies Into Clinical Practice

EP: 8.Key Takeaways for AD Management

Video content above is prompted by the following:

What are some key considerations dermatologists should keep in mind when integrating newer therapies into their clinical practice (e.g., implementing protocols for patient monitoring, promoting treatment adherence)?

Related Content

Value-Based Decision-Making in Metastatic Breast Cancer

Ian E. Krop, MD, PhD;Debra Patt, MD, PhD, MBA

September 16th 2021

Article

In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.